# Bioequivalence of Orfadin 20 mg Compared to Orfadin 10 mg Capsules.

> **NCT01857362** · PHASE1 · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nitisinone 20 mg
- **DRUG:** Nitisinone 10 mg

## Key facts

- **NCT ID:** NCT01857362
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857362, "Bioequivalence of Orfadin 20 mg Compared to Orfadin 10 mg Capsules.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01857362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*